Try our mobile app

Published: 2022-02-08 00:00:00 ET
<<<  go to CTS company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 104.144.139.170:3128 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Tue, 08 Feb 2022 12:46:26 GMT server: AmazonS3 x-amz-id-2: W2cMtLlplhQR5mFvTdjT9TPi32GW5Irw9tE1IEkf7c+8Dr3KjQV5aioceauQFe4oYRseqb3xYBY= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1644324382/atime:1644324382/md5:6394c949fdb7cc523f8571bfed272c6a/ctime:1644324384 x-amz-replication-status: COMPLETED x-amz-request-id: XANMVER2RTDA3CC8 x-amz-version-id: caCdunnx1xkRcNS0ofliOTZYesWo95GR x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 26486 0 pmb=mTOE,2 expires: Thu, 06 Apr 2023 18:13:07 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Thu, 06 Apr 2023 18:13:07 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=742511DEC48930B7D11F957C6D157D3D~000000000000000000000000000000~YAAQDPzDF9M+NhKHAQAAxrXFVxOdHeANSS7xkgcWUOlHwKze4BwWjdnu70MnkKrR4AuZpXrab3efNRrGP8kjkM8JT/M5MIEwFQPUpedSP9v9jEVLt2GPnhOiwjD57rgJ/EowqhgQ2eArNuvapEsudfmHDxVGTpHjsWtmV0pmwrqEFCXLF8BadOFhb2QaZ39e+TSQueJAy5I3XAwBoXL2lssFs0SkqN8rCmI/nRv/T7v28Opykvsc/Ub3kDi/EhZrPYfjfjMYWVNbGbkMERU9SZ5ySsLN4XB8B20p6w9/OxZRn/kOWf+t9YNK3t1dVQgSDhpxF1HgiyJvJ4sM+nbFNjvobcBjhiF9ywI/5Yp4/k/NOSA/NoTQDcY49Sul2UX5Yjfr60RwxUIY; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 20:13:07 GMT; Max-Age=7200; HttpOnly set-cookie: bm_mi=AE69DEE4A977D40638CABBA950D90600~YAAQDPzDF9Q+NhKHAQAAxrXFVxMbItejcC2cdAMNRnqiQefhDa0kr8wbtbHxljl2Qq7KgARyCnTzfqpSVDvbICegsXT7C2gESkOcGH9bH99JaWLRzC7Db8WkK1+FfD1PuqKCSuEEWHAXrNdKFuhWAglboEMCkQk3mZEJ6xou7Gz7hPN5wNAGpLE0Q09FvBorYro0GXxlvzIZUHzGeEeM/L1SqHbqab/fjw3S6ymi9GID08mghIW4FbLUHZfoycCBQ17VZyxTy3RZAz2HvOE0yz8HGezo6Cxt3YXiR0OD3hXW+yowhrgQjEYisIoPURJK04z3h4IhyFGVhZ2vfYBYTF/2kFqkWlW4nOMnSdOg2HB8WY/5Qc9XbYR8MZJ8obqVhzK8rurM~1; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 18:13:07 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close EX-99.1 2 cts-ex991_6.htm EX-99.1 cts-ex991_6.htm

Press Release

 

 

February 8, 2022            FOR IMMEDIATE RELEASE

 

 

CTS Announces Fourth Quarter and Full Year 2021 Results

Delivering Solid Growth and Diversification

 

Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “sense, connect and move” today announced fourth quarter and full year 2021 results.

 

“We delivered strong growth across all end markets despite a challenging macroeconomic environment. Importantly, we also further advanced our diversification strategy, which was underscored by a 25% increase in non-transportation revenues over the previous year, while at the same time winning record new business across end markets,” said Kieran O’Sullivan, CEO of CTS Corporation.

 

“We enter 2022 with a goal to continue our progress on profitable growth and diversification. The investments we’ve made in the business combined with our strong balance sheet and disciplined capital allocation approach will enable us to capitalize on future growth opportunities and continue to return value to our shareholders.”

 

Fourth Quarter 2021 Results

 

Sales were $132.5 million, up 8% year-over-year. Sales to non-transportation end markets increased 25%, and sales to the transportation end market decreased 3% over the same period.

Net income was $9.2 million, or $0.28 per diluted share, compared to $14.9 million, or $0.46 per diluted share, in the fourth quarter of 2020. The lower net income was due to increased foreign exchange expense and a higher tax rate.

Adjusted diluted EPS was $0.49, up from $0.43 in the fourth quarter of 2020.

Adjusted EBITDA margin was 20.9% compared to 21.4% in the fourth quarter of 2020.

Operating cash flow was $26.0 million, compared to $26.4 million in the fourth quarter of 2020.

New business wins were $185 million, up from $104 million in the fourth quarter of 2020.

 

Full Year 2021 Results

 

Sales were $512.9 million, up 21% year-over-year. Sales to non-transportation end markets increased 25%, and sales to the transportation end market increased 18% over the same period.

Net loss was $41.9 million, or $(1.30) per diluted share, versus net earnings of $34.7 million, or $1.06 per diluted share, in 2020. The 2021 net earnings were impacted by non-cash charges of $96.6 million, net of taxes related to the previously disclosed termination of the U.S. pension plan.

Adjusted diluted EPS was $1.93, up from $1.12 in 2020.

Adjusted EBITDA margin was 21.0% compared to 18.3% for 2020.

Operating cash flow was $86.1 million, up from $76.8 million in 2020.

New business wins were $694 million, up from $442 million in 2020.

 

 

 

 

 

www.ctscorp.com

 


 

2022 Guidance

 

CTS expects full year 2022 sales to be in the range of $525 – $550 million and adjusted diluted EPS in the range of $2.00 – $2.25.

 

Conference Call and Supplemental Materials

 

As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EST) today to discuss the fourth quarter and full year 2021 financial results. The dial-in number for the U.S. and Canada is 844-200-6205 (+1 929-526-1599, if calling from outside the U.S.).  The passcode is 160107. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://www.ctscorp.com/investors/events-presentations/

 

About CTS

 

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move.  The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

 

Safe Harbor

 

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect CTS’ current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause CTS’ actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: the ultimate impact of the COVID-19 pandemic on CTS’ business, results of operations or financial condition; changes in the economy generally and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions; the results of actions to reposition CTS’  business; rapid technological change; general market conditions in the transportation industry, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; and risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update its forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

 

 

 

 

 

 

www.ctscorp.com

 


 

Non-GAAP Financial Measures

 

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS’ management believes that non-GAAP financial measures can be useful to investors in analyzing CTS’ financial performance and results of operations over time. CTS recommends that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.

 

The information included in this press release includes the non-GAAP financial measures of adjusted operating earnings, adjusted EBITDA, adjusted net earnings, adjusted diluted earnings per share, debt to capitalization ratio, controllable working capital ratio, and free cash flow. Many of these non-GAAP financial measures exclude the effect of certain expenses and income not related directly to the underlying performance of CTS’ fundamental business operations.

 

CTS believes that adjusted operating earnings, adjusted EBITDA, adjusted net earnings and, adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations or were not part of CTS’ business operations during a comparable period.

 

CTS believes that debt to capitalization ratio is a measurement of financial leverage and provides an insight into the financial structure of CTS and its financial strength. CTS believes the controllable working capital ratio provides an objective measure of the efficiency with which CTS manages its short-term capital needs.  CTS believes that free cash flow is a useful measure of its ability to generate cash.

 

CTS believes that these non-GAAP financial measures are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. Note that CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies.

 

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

 

Contact

 

Ashish Agrawal

Vice President and Chief Financial Officer

CTS Corporation

4925 Indiana Avenue

Lisle, IL 60532 USA

+1 (630) 577-8800

ashish.agrawal@ctscorp.com

www.ctscorp.com

 


CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - UNAUDITED

(In thousands of dollars, except per share amounts)

 

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

December 31,

2021

 

 

December 31,

2020

 

 

December 31,

2021

 

 

December 31,

2020

 

Net sales

 

$

132,531

 

 

$

123,018

 

 

$

512,925

 

 

$

424,066

 

Cost of goods sold

 

 

83,860

 

 

 

80,327

 

 

 

328,306

 

 

 

285,003

 

Gross margin

 

 

48,671

 

 

 

42,691

 

 

 

184,619

 

 

 

139,063

 

Selling, general and administrative expenses

 

 

23,413

 

 

 

19,476

 

 

 

82,597

 

 

 

67,787

 

Research and development expenses

 

 

5,686

 

 

 

5,664

 

 

 

23,856

 

 

 

24,317

 

Restructuring charges

 

 

1,136

 

 

 

414

 

 

 

1,687

 

 

 

1,830

 

Operating earnings

 

 

18,436

 

 

 

17,137

 

 

 

76,479

 

 

 

45,129

 

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(534

)

 

 

(655

)

 

 

(2,111

)

 

 

(3,272

)

Interest income

 

 

151

 

 

 

195

 

 

 

840

 

 

 

1,047

 

Other (expense) income, net

 

 

(3,302

)

 

 

2,682

 

 

 

(136,088

)

 

 

2,575

 

Total other (expense) income, net

 

 

(3,685

)

 

 

2,222

 

 

 

(137,359

)

 

 

350

 

Earnings (loss) before income taxes

 

 

14,751

 

 

 

19,359

 

 

 

(60,880

)

 

 

45,479

 

Income tax expense (benefit)

 

 

5,586

 

 

 

4,412

 

 

 

(19,014

)

 

 

10,793

 

Net earnings (loss)

 

 

9,165

 

 

 

14,947

 

 

 

(41,866

)

 

$

34,686

 

Earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.28

 

 

$

0.46

 

 

$

(1.30

)

 

$

1.07

 

Diluted

 

$

0.28

 

 

$

0.46

 

 

$

(1.30

)

 

$

1.06

 

Basic weighted – average common shares outstanding:

 

 

32,214

 

 

 

32,273

 

 

 

32,327

 

 

 

32,317

 

Effect of dilutive securities

 

 

218

 

 

 

289

 

 

 

 

 

 

267

 

Diluted weighted – average common shares outstanding:

 

 

32,432

 

 

 

32,562

 

 

 

32,327

 

 

 

32,584

 

Cash dividends declared per share

 

$

0.04

 

 

$

0.04

 

 

$

0.16

 

 

$

0.16

 

 

 

 

 

 

www.ctscorp.com

 


 

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

 

 

 

(Unaudited)

 

 

 

 

 

 

 

December 31, 2021

 

 

December 31, 2020

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

141,465

 

 

$

91,773

 

Accounts receivable, net

 

 

82,191

 

 

 

80,981

 

Inventories, net

 

 

49,506

 

 

 

45,870

 

Other current assets

 

 

15,927

 

 

 

14,607

 

Total current assets

 

 

289,089

 

 

 

233,231

 

Property, plant and equipment, net

 

 

96,876

 

 

 

97,437

 

Operating lease assets, net

 

 

21,594

 

 

 

23,281

 

Other Assets

 

 

 

 

 

 

 

 

Prepaid pension asset

 

 

49,382

 

 

 

56,642

 

Goodwill

 

 

109,798

 

 

 

109,497

 

Other intangible assets, net

 

 

69,888

 

 

 

79,121

 

Deferred income taxes

 

 

25,415

 

 

 

24,250

 

Other

 

 

2,420

 

 

 

2,590

 

Total other assets

 

 

256,903

 

 

 

272,100

 

Total Assets

 

$

664,462

 

 

$

626,049

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

55,537

 

 

$

50,489

 

Operating lease obligations

 

 

3,393

 

 

 

3,294

 

Accrued payroll and benefits

 

 

18,418

 

 

 

12,978

 

Accrued expenses and other liabilities

 

 

36,718

 

 

 

38,171

 

Total current liabilities

 

 

114,066

 

 

 

104,932

 

Long-term debt

 

 

50,000

 

 

 

54,600

 

Long-term operating lease obligations

 

 

21,354

 

 

 

23,163

 

Long-term pension obligations

 

 

6,886

 

 

 

7,466

 

Deferred income taxes

 

 

5,894

 

 

 

7,010

 

Other long-term obligations

 

 

2,684

 

 

 

5,196

 

Total Liabilities

 

 

200,884

 

 

 

202,367

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

 

 

 

Common stock

 

 

314,620

 

 

 

311,190

 

Additional contributed capital

 

 

42,549

 

 

 

41,654

 

Retained earnings

 

 

492,242

 

 

 

539,281

 

Accumulated other comprehensive loss

 

 

(4,525

)

 

 

(95,921

)

Total shareholders’ equity before treasury stock

 

 

844,886

 

 

 

796,204

 

Treasury stock

 

 

(381,308

)

 

 

(372,522

)

Total shareholders’ equity

 

 

463,578

 

 

 

423,682

 

Total Liabilities and Shareholders’ Equity

 

$

664,462

 

 

$

626,049

 

www.ctscorp.com

 


 

CTS CORPORATION AND SUBSIDIARIES

OTHER SUPPLEMENTAL INFORMATION - UNAUDITED

(In millions of dollars, except per share amounts)

 

Adjusted Operating Earnings

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

Operating earnings

 

$

18.4

 

 

$

17.1

 

 

$

76.5

 

 

$

45.1

 

 

$

53.8

 

Adjustments to reported operating earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

1.1

 

 

 

0.4

 

 

 

1.7

 

 

 

1.8

 

 

 

7.4

 

Environmental charges

 

 

1.4

 

 

 

1.5

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

 

 

 

0.3

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Total adjustments to reported operating earnings

 

$

2.5

 

 

$

2.2

 

 

$

3.9

 

 

$

4.9

 

 

$

10.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating earnings

 

$

21.0

 

 

$

19.4

 

 

$

80.4

 

 

$

50.0

 

 

$

63.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

132.5

 

 

$

123.0

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating earnings as a % of net sales

 

 

15.8%

 

 

 

15.7%

 

 

 

15.7%

 

 

 

11.8%

 

 

 

13.6%

 

 

Adjusted EBITDA

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

Net earnings (loss)

 

$

9.2

 

 

$

14.9

 

 

$

(41.9

)

 

$

34.7

 

 

$

36.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense

 

 

6.7

 

 

 

6.9

 

 

 

26.9

 

 

 

26.7

 

 

 

24.6

 

Interest expense

 

 

0.5

 

 

 

0.7

 

 

 

2.1

 

 

 

3.3

 

 

 

2.6

 

Tax expense (benefit)

 

 

5.6

 

 

 

4.4

 

 

 

(19.0

)

 

 

10.8

 

 

 

14.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

 

22.0

 

 

 

26.9

 

 

 

(31.8

)

 

 

75.4

 

 

 

77.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments to EBITDA:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

1.1

 

 

 

0.4

 

 

 

1.7

 

 

 

1.8

 

 

 

6.9

 

Environmental charges

 

 

1.4

 

 

 

1.5

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

 

 

 

0.3

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Non-cash pension expense

 

 

1.3

 

 

 

0.6

 

 

 

132.4

 

 

 

2.5

 

 

 

0.8

 

Foreign currency loss (gain)

 

 

1.9

 

 

 

(3.4

)

 

 

3.3

 

 

 

(5.3

)

 

 

1.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total adjustments to EBITDA

 

 

5.7

 

 

 

(0.5

)

 

 

139.7

 

 

 

2.1

 

 

 

12.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

27.7

 

 

$

26.5

 

 

$

107.8

 

 

$

77.5

 

 

$

89.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

132.5

 

 

$

123.0

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA as a % of net sales

 

 

20.9

%

 

 

21.4

%

 

 

21.0

%

 

 

18.3

%

 

 

19.1

%

www.ctscorp.com

 


 

Adjusted Net Earnings

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

Net earnings (loss) (A)

 

$

9.2

 

 

$

14.9

 

 

$

(41.9

)

 

$

34.7

 

 

$

36.1

 

Adjustments to reported net earnings (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

1.1

 

 

 

0.4

 

 

 

1.7

 

 

 

1.8

 

 

 

7.4

 

Environmental charges

 

 

1.4

 

 

 

1.5

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

 

 

 

0.3

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Non-cash pension expense

 

 

1.3

 

 

 

0.6

 

 

 

132.4

 

 

 

2.5

 

 

 

0.8

 

Foreign currency (gain) loss

 

 

1.9

 

 

 

(3.4

)

 

 

3.3

 

 

 

(5.3

)

 

 

1.8

 

Total adjustments to reported net earnings (loss)

 

$

5.7

 

 

$

(0.5

)

 

$

139.7

 

 

$

2.1

 

 

$

12.6

 

Total adjustments, tax affected (B)

 

$

5.1

 

 

$

(1.2

)

 

$

108.6

 

 

$

0.4

 

 

$

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in valuation allowances

 

 

0.9

 

 

 

(0.6

)

 

 

0.9

 

 

 

0.2

 

 

 

 

Other discrete tax items

 

 

0.7

 

 

 

0.9

 

 

 

(4.7

)

 

 

1.2

 

 

 

1.8

 

Total tax adjustments (C)

 

$

1.6

 

 

$

0.3

 

 

$

(3.8

)

 

$

1.4

 

 

$

1.8

 

Adjusted net earnings (A+B+C)

 

$

15.9

 

 

$

14.1

 

 

$

63.0

 

 

$

36.5

 

 

$

48.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

132.5

 

 

$

123.0

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net earnings as a % of net sales

 

 

12.0

%

 

 

11.5

%

 

 

12.3

%

 

 

8.6

%

 

 

10.3

%

 

Adjusted Diluted Earnings Per Share

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

GAAP diluted earnings (loss) per share

 

$

0.28

 

 

$

0.46

 

 

$

(1.30

)

 

$

1.06

 

 

$

1.09

 

Tax affected charges to reported diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.04

 

 

 

0.01

 

 

 

0.06

 

 

 

0.04

 

 

 

0.18

 

Foreign currency loss (gain)

 

 

0.06

 

 

 

(0.10

)

 

 

0.10

 

 

 

(0.16

)

 

 

0.05

 

Non-cash pension expense

 

 

0.03

 

 

 

0.01

 

 

 

3.13

 

 

 

0.06

 

 

 

0.02

 

Environmental charges

 

 

0.03

 

 

 

0.03

 

 

 

0.05

 

 

 

0.07

 

 

 

0.05

 

Transaction costs

 

 

 

 

 

0.01

 

 

 

 

 

 

0.01

 

 

 

0.02

 

Legal Settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.01

)

Discrete tax items

 

 

0.05

 

 

 

0.01

 

 

 

(0.11

)

 

 

0.04

 

 

 

0.05

 

Adjusted diluted earnings per share

 

$

0.49

 

 

$

0.43

 

 

$

1.93

 

 

$

1.12

 

 

$

1.45

 

 

Debt to Capitalization

 

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Total debt (A)

 

$

50.0

 

 

$

54.6

 

 

$

99.7

 

Total shareholders' equity (B)

 

$

463.6

 

 

$

423.7

 

 

$

405.2

 

Total capitalization (A+B)

 

$

513.6

 

 

$

478.3

 

 

$

504.9

 

Total debt to capitalization

 

 

9.7

%

 

 

11.4

%

 

 

19.7

%

www.ctscorp.com

 


 

Controllable Working Capital

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net accounts receivable

 

$

82.2

 

 

$

81.0

 

 

$

78.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net inventory

 

$

49.5

 

 

$

45.9

 

 

$

42.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

(55.5

)

 

$

(50.5

)

 

$

(48.2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Controllable working capital

 

$

76.2

 

 

$

76.4

 

 

$

72.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter sales

 

$

132.5

 

 

$

123.0

 

 

$

115.0

 

Multiplied by 4

 

 

4

 

 

 

4

 

 

 

4

 

Annualized sales

 

$

530.1

 

 

$

492.1

 

 

$

460.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Controllable working capital as a % of annualized sales

 

 

14.4

%

 

 

15.5

%

 

 

15.7

%

 

Free Cash Flow

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

Net cash provided by operating activities

 

$

26.0

 

 

$

26.4

 

 

$

86.1

 

 

$

76.8

 

 

$

64.4

 

Capital expenditures

 

 

(7.5

)

 

 

(4.4

)

 

 

(15.6

)

 

 

(14.9

)

 

 

(21.7

)

Free cash flow

 

$

18.5

 

 

$

22.0

 

 

$

70.5

 

 

$

61.9

 

 

$

42.7

 

 

Capital Expenditures

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

2019

 

Capital expenditures

 

$

7.5

 

 

$

4.4

 

 

$

15.6

 

 

$

14.9

 

 

$

21.7

 

Net sales

 

$

132.5

 

 

$

123.0

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

Capex as % of net sales

 

 

5.7%

 

 

 

3.6%

 

 

 

3.0%

 

 

 

3.5%

 

 

 

4.6%

 

 

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

 

 

 

Three Months Ended

December 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Depreciation and amortization expense

 

$

6.7

 

 

$

6.9

 

 

$

26.9

 

 

$

26.7

 

Stock-based compensation expense

 

$

2.0

 

 

$

1.3

 

 

$

6.1

 

 

$

3.4

 

 

www.ctscorp.com